Danh mục

Báo cáo khoa học: Metastatic colorectal cancer to a primary thyroid cancer

Số trang: 5      Loại file: pdf      Dung lượng: 773.02 KB      Lượt xem: 7      Lượt tải: 0    
10.10.2023

Hỗ trợ phí lưu trữ khi tải xuống: miễn phí Tải xuống file đầy đủ (5 trang) 0
Xem trước 2 trang đầu tiên của tài liệu này:

Thông tin tài liệu:

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Metastatic colorectal cancer to a primary thyroid cancer
Nội dung trích xuất từ tài liệu:
Báo cáo khoa học: "Metastatic colorectal cancer to a primary thyroid cancer"World Journal of Surgical Oncology BioMed Central Open AccessCase reportMetastatic colorectal cancer to a primary thyroid cancerMartin H Cherk*1, Maggie Moore2, Jonathan Serpell3, Sarah Swain4 andDuncan J Topliss5Address: 1Department of Nuclear Medicine, the Alfred Hospital, Commercial Road, Melbourne Victoria 3004, Australia, 2Department of MedicalOncology, the Alfred Hospital, Commercial Road, Melbourne Victoria 3004, Australia, 3Department of Surgery, the Alfred Hospital, CommercialRoad, Melbourne Victoria 3004, Australia, 4Department of Anatomical Pathology, the Alfred Hospital, Commercial Road, Melbourne Victoria3004, Australia and 5Department of Endocrinology and Diabetes, the Alfred Hospital, Commercial Road, Melbourne Victoria 3004, AustraliaEmail: Martin H Cherk* - m_cherk@yahoo.com.au; Maggie Moore - Maggie.moore@alfred.org.au;Jonathan Serpell - Jonathan.serpell@alfred.org.au; Sarah Swain - S.swain@alfred.org.au; Duncan J Topliss - D.topliss@alfred.org.au* Corresponding authorPublished: 11 November 2008 Received: 22 August 2008 Accepted: 11 November 2008World Journal of Surgical Oncology 2008, 6:122 doi:10.1186/1477-7819-6-122This article is available from: http://www.wjso.com/content/6/1/122© 2008 Cherk et al; licensee BioMed Central Ltd.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Metastatic malignancy to the thyroid gland is generally uncommon due to an unfavourable local thyroid micro-environment which impairs the ability of metastatic cells to settle and thrive. Metastases to the thyroid gland have however been reported to occur occasionally particularly if there has been disruption to normal thyroid tissue architecture. Case presentation: We report a patient with a history of surgically resected rectal adenocarcinoma who presents with a rising serum CEA level and an 18F-FDG PET scan positive thyroid nodule which was subsequently confirmed at surgery to be a focus of metastatic rectal adenocarcinoma within a primary poorly differentiated papillary thyroid carcinoma. Subsequent treatment involved right hemi-thyroidectomy, pulmonary wedge resection of oligometastatic metastatic colorectal cancer and chemotherapy. Conclusion: Metastatic rectal carcinoma to the thyroid gland and in particular to a primary thyroid malignancy is rare and unusual. Prognosis is likely to be more dependent on underlying metastatic disease rather than the primary thyroid malignancy hence primary treatments should be tailored towards treating and controlling metastatic disease and less emphasis placed on the primary thyroid malignancy. previously published reports of metastatic malignancy toBackgroundMetastatic malignancy to the thyroid gland, although con- a primary thyroid malignancy.sidered rare, occurs more frequently than expected. Micro-scopic metastases to the thyroid gland have been reported Case presentationto occur in 4%–9% of autopsy studies[1,2], with breast, A 52 year old man with a history of T3N1M0 (Dukes C)lung, melanoma and kidney the most common primary rectal adenocarcinoma treated with neo-adjuvant chemo-malignancies. Metastatic colorectal cancer to the thyroid radiotherapy (5FU + radiotherapy) followed by anteriorgland is considered unusual, with 33 previous cases resection and adjuvant chemotherapy (5FU) presented 18reported in the literature up till 2008 [3-6]. There are no months post completion of therapy with rising serum Page 1 of 5 ...

Tài liệu được xem nhiều:

Tài liệu liên quan: